Interferon Beta-1B — supply status, manufacturers & alternatives

Interferon Beta-1B

—

🇦🇺 AUST R 83309 · Bayer Australia Ltd

In supply · Australia

Extavia

In supply · 🇦🇺 Australia

In supply in Australia

No active shortage reported.

Reading today’s signals…

🇦🇺 AUAEMPA$668.82DPMQ A$741.82details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Brand names
Active ingredient (INN)	Interferon Beta-1B

Therapeutic category	Auto-created by EMA — Withdrawn / Refused / Revoked Medicines scraper

Controlled substance	No

Marketing-authorisation holders	Bayer Australia Ltd

Registrations on file	1

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$668.82

AEMP

Dispensed (DPMQ)

A$741.82

incl. fees

Pack

interferon beta-1b 8 million units (250 microgram) injection [15 vials] (&) inert substance diluent [15 x 1.2 mL syringes], 1 pack

Source: PBSEffective July 2026 · AUD

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 2 resolved events

◷

~0 month

Historical pattern from resolved shortage records — not a prediction of this event.

FDA-approved products 🇺🇸 Drugs@FDA

Approved applications

Generic (ANDA)

Brand (NDA/BLA)

Dec 2015

Latest approval

Shortage status by regulator official notices

🇳🇴

Norway

NOMA · 20h ago

Resolved

Recalls official enforcement reports

🌐

Extavia

Novartis Europharm Limited · Apr 2025

Class Unifieddetails ↗

Verified timeline regulator events

🇳🇴 21 Jan 2026

Shortage resolved

🇳🇴 24 Nov 2025

Shortage resolved

Sources official regulators

🇳🇴

NOMA

verified 20h ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders1 registration · 1 MA holder

Product	Strength	Form	Market	MA holder	Status
BETAFERON interferon beta-1b rbe	0.25mg	—	🇦🇺 AU	Bayer Australia Ltd	Active

Mederti Drug Report

Generated 6 July 2026 · Australia market · 1 regulatory source

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.